The aim of this study was to investigate whether decreased serum fetuin-A concentration could be a helpful parameter to identify patients with Wilson’s disease who developed cirrhosis, and whether genetic alterations and ceruloplasmin levels influence serum concentration of fetuin-A and thus could hinder its diagnostic use. This evidence concerns the gene AHSG and Wilson disease.